RRC ID 65662
著者 Ando H, Eshima K, Ishida T.
タイトル Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model.
ジャーナル Biol Pharm Bull
Abstract Extracellular pH (pHe) of tumor cells is characteristic of tumor microenvironment (TME). Acidic TME impairs the responses of tumors to some anti-cancer chemotherapies. In this study, we showed that daily oral dosing of sodium potassium citrate (K/Na citrate) increased blood HCO3- concentrations, corresponding to increase of HCO3- concentrations and pHs in urine, and neutralized the tumor pHe. Neutralization of acidic TME by alkaline substance like HCO3-, an active metabolite of K/Na citrate, well potentiated the therapeutic effect of anticancer agent TS-1®, an orally active 5-fuluoro-uracil derivative, in Panc-1 pancreatic cancer-xenograft murine model. Neutralization of acidic TME by using an alkaline K/Na citrate is a smart approach for enhancement of the therapeutic effects of anticancer agents for pancreatic cancer in the end stage.
巻・号 44(2)
ページ 266-270
公開日 2021-1-1
DOI 10.1248/bpb.b20-00825
PMID 33518679
MeSH Administration, Oral Animals Antacids / administration & dosage* Antacids / pharmacokinetics Cell Line, Tumor Drug Combinations Drug Synergism Extracellular Space / chemistry Extracellular Space / drug effects Female Humans Hydrogen-Ion Concentration / drug effects* Mice Oxonic Acid / administration & dosage* Oxonic Acid / pharmacokinetics Oxonic Acid / therapeutic use Pancreatic Neoplasms / drug therapy* Pancreatic Neoplasms / pathology Potassium Citrate / administration & dosage Potassium Citrate / pharmacokinetics Sodium Citrate / administration & dosage Sodium Citrate / pharmacokinetics Tegafur / administration & dosage* Tegafur / pharmacokinetics Tegafur / therapeutic use Tumor Microenvironment / drug effects* Xenograft Model Antitumor Assays
IF 1.863
リソース情報
ヒト・動物細胞 PANC-1(RCB2095)